Artelo Biosciences, Inc. SEC filings ARTL
Artelo Biosciences, Inc. has 465 filings in SEC EDGAR's recent list, going back to Oct 8, 2014. Its latest annual report, Form ARS, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | May 26, 2026 | — |
| 424B5 | Prospectus supplement | May 18, 2026 | — |
| S-3/A | Form s-3/a | May 14, 2026 | — |
| S-3 | Shelf registration | May 4, 2026 | — |
| 424B3 | Prospectus | Apr 16, 2026 | — |
| S-1 | Registration statement | Apr 7, 2026 | — |
| S-1 | Registration statement | Mar 24, 2026 | — |
| S-1/A | Amended registration statement | Mar 24, 2026 | — |
| S-1/A | Amended registration statement | Mar 23, 2026 | — |
| S-1 | Registration statement | Mar 20, 2026 | — |
| S-1 | Registration statement | Nov 17, 2025 | — |
| 424B5 | Prospectus supplement | Oct 1, 2025 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| 424B5 | Prospectus supplement | Sep 5, 2025 | — |
| 424B5 | Prospectus supplement | Sep 4, 2025 | — |
| 424B5 | Prospectus supplement | Sep 4, 2025 | — |
| 424B5 | Prospectus supplement | Jul 18, 2025 | — |
| S-1 | Registration statement | Jul 11, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| S-3 | Shelf registration | Jul 6, 2023 | — |
| S-8 | Employee stock plan registration | Apr 21, 2023 | — |
| 424B3 | Prospectus | Jun 2, 2022 | — |
| S-1 | Registration statement | May 16, 2022 | — |
| S-8 | Employee stock plan registration | Apr 7, 2022 | — |
| 424B5 | Prospectus supplement | Apr 9, 2021 | — |
| POS AM | Posam | Jan 21, 2021 | — |
| POS AM | Posam | Jan 15, 2021 | — |
| POS AM | Filing | Jan 15, 2021 | — |
| S-8 | Employee stock plan registration | Dec 16, 2020 | — |
| 424B4 | Prospectus | Oct 13, 2020 | — |
| S-1MEF | Filing | Oct 9, 2020 | — |
| S-1/A | Amended registration statement | Oct 8, 2020 | — |
| S-1/A | Amended registration statement | Oct 7, 2020 | — |
| FWP | Free writing prospectus | Oct 6, 2020 | — |
| S-1/A | Amended registration statement | Oct 6, 2020 | — |
| S-1 | Registration statement | Sep 28, 2020 | — |
| 424B5 | Prospectus supplement | Jul 14, 2020 | — |
| S-8 | Employee stock plan registration | Jun 25, 2020 | — |
| 424B5 | Prospectus supplement | Apr 15, 2020 | — |
| 424B5 | Prospectus supplement | Apr 14, 2020 | — |
| POS AM | Filing | Apr 7, 2020 | — |
| S-3 | Shelf registration | Jan 15, 2020 | — |
| S-8 | Employee stock plan registration | Jan 15, 2020 | — |
| S-3/A | Form s-3 amendment no. 2 | Dec 19, 2019 | — |
| S-3/A | Form s-3 amendment no. 1 | Nov 25, 2019 | — |
| S-3/A | Form s-3 amendment no. 1 | Nov 25, 2019 | — |
| S-3 | Shelf registration | Oct 30, 2019 | — |
| S-3 | Shelf registration | Jul 26, 2019 | — |
| 424B4 | Prospectus | Jun 25, 2019 | — |
| S-1/A | Amended registration statement | Jun 20, 2019 | — |
| S-1/A | Amended registration statement | Jun 10, 2019 | — |
| S-1/A | Amended registration statement | May 31, 2019 | — |
| S-1/A | Amended registration statement | May 29, 2019 | — |
| S-1 | Registration statement | Apr 1, 2019 | — |
| S-1 | Registration statement | Sep 27, 2018 | — |
| 424B3 | Prospectus | Jul 27, 2018 | — |
| 424B3 | Prospectus | May 30, 2018 | — |
| S-1/A | Amended registration statement | May 14, 2018 | — |
| S-1/A | Amended registration statement | Apr 17, 2018 | — |
| S-1/A | Amended registration statement | Mar 21, 2018 | — |
| S-1 | Registration statement | Jan 29, 2018 | — |
| S-1/A | Amended registration statement | Jan 23, 2015 | — |
| S-1/A | Amended registration statement | Dec 24, 2014 | — |
| S-1 | Registration statement | Oct 8, 2014 | — |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1621221
- Former names
- REACTIVE MEDICAL INC. (until Apr 17, 2017); KNIGHT KNOX DEVELOPMENT CORP. (until Feb 6, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.